Complete financial analysis of Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sichuan Kelun Pharmaceutical Co., Ltd., a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
You may be interested
- Jasmine International Public Company Limited (JASUF) Income Statement Analysis – Financial Results
- HIVE Blockchain Technologies Ltd. (HBF.F) Income Statement Analysis – Financial Results
- Bank OZK (OZKAP) Income Statement Analysis – Financial Results
- Paras Defence and Space Technologies Limited (PARAS.BO) Income Statement Analysis – Financial Results
- Nova Ljubljanska Banka d.d. (NLB.L) Income Statement Analysis – Financial Results
Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)
About Sichuan Kelun Pharmaceutical Co., Ltd.
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers IV solutions; injectable powder and small volume parenteral; oral preparation; intermediates and APIs; and peritoneal dialysis solutions. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. is a subsidiary of Sichuan Kelun Industry Group CO., LTD.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21.45B | 18.91B | 17.28B | 16.46B | 17.64B | 16.35B | 11.43B | 8.57B | 7.76B | 8.02B | 6.83B | 5.89B | 5.15B | 4.03B | 3.25B | 2.62B | 2.03B |
| Cost of Revenue | 10.29B | 8.96B | 7.66B | 7.53B | 7.02B | 6.61B | 5.57B | 4.85B | 4.51B | 4.61B | 3.71B | 3.37B | 2.94B | 2.37B | 1.99B | 1.67B | 1.30B |
| Gross Profit | 11.16B | 9.95B | 9.62B | 8.93B | 10.61B | 9.74B | 5.87B | 3.71B | 3.26B | 3.42B | 3.12B | 2.51B | 2.20B | 1.65B | 1.25B | 948.38M | 731.77M |
| Gross Profit Ratio | 52.03% | 52.63% | 55.66% | 54.25% | 60.18% | 59.56% | 51.31% | 43.33% | 41.96% | 42.57% | 45.66% | 42.67% | 42.79% | 41.05% | 38.66% | 36.18% | 36.06% |
| Research & Development | 1.95B | 1.80B | 1.74B | 1.53B | 1.29B | 885.23M | 712.21M | 547.44M | 434.16M | 312.35M | 300.06M | 186.54M | 136.43M | 71.44M | 34.91M | 10.43M | 11.03M |
| General & Administrative | 382.89M | 311.69M | 319.98M | 294.87M | 213.21M | 160.86M | 125.03M | 183.12M | 165.88M | 152.47M | 110.01M | 97.24M | 81.61M | 84.60M | 49.75M | 45.44M | 47.65M |
| Selling & Marketing | 4.45B | 4.69B | 5.02B | 4.88B | 6.55B | 5.99B | 3.07B | 1.25B | 1.03B | 1.05B | 887.04M | 696.75M | 692.36M | 592.44M | 500.89M | 394.46M | 311.09M |
| SG&A | 5.63B | 5.00B | 5.34B | 5.18B | 6.76B | 6.15B | 3.20B | 1.44B | 1.19B | 1.20B | 997.05M | 793.98M | 773.98M | 677.04M | 550.64M | 439.90M | 358.74M |
| Other Expenses | -65.90M | 626.90M | 829.69M | 590.60M | 753.48M | -22.80M | -15.56M | 63.96M | 112.10M | 75.81M | 146.65M | 138.17M | 60.12M | 30.88M | 26.01M | 2.59M | 9.96M |
| Operating Expenses | 7.51B | 7.42B | 7.91B | 7.30B | 8.80B | 7.77B | 4.62B | 2.63B | 2.16B | 1.98B | 1.65B | 1.27B | 1.13B | 886.82M | 698.68M | 544.80M | 446.66M |
| Cost & Expenses | 17.80B | 16.38B | 15.57B | 14.83B | 15.83B | 14.39B | 10.18B | 7.48B | 6.67B | 6.58B | 5.36B | 4.65B | 4.07B | 3.26B | 2.69B | 2.22B | 1.74B |
| Interest Income | 103.59M | 44.22M | 29.20M | 30.38M | 26.22M | 26.69M | 27.84M | 40.23M | 52.14M | 61.23M | 61.90M | 52.75M | 70.04M | 49.57M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 370.71M | 473.71M | 518.34M | 554.86M | 584.83M | 613.84M | 536.06M | 337.17M | 301.89M | 264.23M | 210.36M | 138.45M | 71.27M | 54.53M | 46.06M | 46.97M | 30.68M |
| Depreciation & Amortization | 1.26B | 1.20B | 1.23B | 1.16B | 1.08B | 988.98M | 805.66M | 655.19M | 568.74M | 496.35M | 325.69M | 231.73M | 185.74M | 92.61M | 74.89M | 61.78M | 50.30M |
| EBITDA | 4.86B | 3.52B | 2.81B | 2.61B | 2.77B | 2.81B | 2.49B | 1.72B | 1.61B | 1.91B | 1.78B | 1.64B | 1.38B | 922.23M | 631.13M | 465.37M | 335.41M |
| EBITDA Ratio | 22.64% | 20.14% | 17.43% | 16.96% | 17.28% | 18.71% | 24.54% | 21.72% | 21.17% | 25.90% | 29.15% | 28.11% | 26.83% | 23.25% | 19.88% | 18.05% | 16.94% |
| Operating Income | 3.65B | 2.20B | 1.79B | 1.64B | 1.98B | 1.36B | 1.16B | 668.06M | 573.50M | 1.09B | 1.15B | 1.13B | 1.06B | 754.41M | 505.56M | 353.11M | 246.47M |
| Operating Income Ratio | 17.03% | 11.63% | 10.38% | 9.95% | 11.21% | 8.29% | 10.12% | 7.80% | 7.39% | 13.57% | 16.81% | 19.28% | 20.60% | 18.74% | 15.57% | 13.47% | 12.15% |
| Total Other Income/Expenses | -73.72M | -127.22M | -615.65M | -683.29M | -720.38M | -22.80M | -15.56M | -371.20M | 107.31M | 59.96M | 133.97M | 133.70M | 58.12M | 20.69M | -29.70M | -48.57M | -20.99M |
| Income Before Tax | 3.58B | 2.07B | 1.18B | 955.03M | 1.26B | 1.33B | 1.14B | 716.43M | 680.82M | 1.15B | 1.28B | 1.27B | 1.12B | 775.10M | 521.92M | 351.51M | 256.15M |
| Income Before Tax Ratio | 16.69% | 10.95% | 6.82% | 5.80% | 7.12% | 8.15% | 9.98% | 8.36% | 8.77% | 14.32% | 18.77% | 21.55% | 21.72% | 19.25% | 16.08% | 13.41% | 12.62% |
| Income Tax Expense | 933.79M | 364.00M | 309.50M | 163.55M | 234.75M | 65.92M | 330.19M | 92.10M | 138.93M | 164.03M | 191.01M | 174.87M | 157.05M | 113.41M | 87.74M | 40.55M | 40.67M |
| Net Income | 2.46B | 1.71B | 868.12M | 829.39M | 937.86M | 1.21B | 748.54M | 584.64M | 645.27M | 1.00B | 1.08B | 1.09B | 966.13M | 661.23M | 427.85M | 309.89M | 216.29M |
| Net Income Ratio | 11.45% | 9.02% | 5.02% | 5.04% | 5.32% | 7.42% | 6.55% | 6.83% | 8.31% | 12.49% | 15.80% | 18.48% | 18.77% | 16.42% | 13.18% | 11.82% | 10.66% |
| EPS | 1.69 | 1.22 | 0.61 | 0.58 | 0.66 | 0.85 | 0.52 | 0.41 | 0.45 | 0.70 | 0.75 | 0.76 | 0.67 | 0.51 | 0.40 | 0.29 | 0.21 |
| EPS Diluted | 1.59 | 1.15 | 0.61 | 0.58 | 0.66 | 0.85 | 0.52 | 0.41 | 0.45 | 0.70 | 0.75 | 0.76 | 0.67 | 0.51 | 0.40 | 0.29 | 0.21 |
| Weighted Avg Shares Out | 1.45B | 1.40B | 1.41B | 1.43B | 1.42B | 1.43B | 1.43B | 1.43B | 1.43B | 1.43B | 1.44B | 1.44B | 1.44B | 1.29B | 1.08B | 1.06B | 1.01B |
| Weighted Avg Shares Out (Dil) | 1.54B | 1.49B | 1.41B | 1.43B | 1.42B | 1.43B | 1.44B | 1.43B | 1.43B | 1.43B | 1.44B | 1.44B | 1.44B | 1.29B | 1.08B | 1.06B | 1.01B |
No news found for: 002422.SZ
Source: https://incomestatements.info
Category: Stock Reports